BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4717764)

  • 21. AICA riboside improves myocardial ischemia in coronary microembolization in dogs.
    Hori M; Kitakaze M; Takashima S; Morioka T; Sato H; Minamino T; Node K; Komamura K; Inoue M; Kamada T
    Am J Physiol; 1994 Oct; 267(4 Pt 2):H1483-95. PubMed ID: 7943395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of cyclic AMP in the modulation of cardiac contractility.
    Entman ML
    Adv Cyclic Nucleotide Res; 1974; 4(0):163-93. PubMed ID: 4369353
    [No Abstract]   [Full Text] [Related]  

  • 23. [Basis of the active mechanism of cardioactive glycoside].
    Schoner W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():6-18. PubMed ID: 148185
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of 2-deoxy-glucose and 3-methyl-glucose on insulin-stimulated lipogenesis in the chick embryo heart.
    Berger CK; Foà PP
    Horm Metab Res; 1971 Mar; 3(2):98-102. PubMed ID: 5123989
    [No Abstract]   [Full Text] [Related]  

  • 25. Incorporation and turnover of adenosine-U- 14 C in perfused guinea pig myocardium.
    Wiedmeier VT; Rubio R; Berne RM
    Am J Physiol; 1972 Jul; 223(1):51-4. PubMed ID: 5039073
    [No Abstract]   [Full Text] [Related]  

  • 26. Homologous desensitization of the A1-adenosine receptor system in the guinea pig atrioventricular node.
    Dennis DM; Shryock JC; Belardinelli L
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1024-35. PubMed ID: 7891312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of phagocytosis on membrane transport of nonelectrolytes.
    Tsan MF; Berlin RD
    J Exp Med; 1971 Oct; 134(4):1016-35. PubMed ID: 5098055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleoside transport inhibition mediates lidoflazine-induced cardioprotection during intermittent aortic crossclamping.
    Chang-Chun C; Masuda M; Szabò Z; Szerafin T; Szècsi J; Van Belle H; Flameng W
    J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1602-9. PubMed ID: 1453724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiologic and pharmacologic roles for the cardiac Na+, K+Atpase transport system.
    Allen JC; Schwartz A
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():30-3. PubMed ID: 4283442
    [No Abstract]   [Full Text] [Related]  

  • 30. [The in vivo measurement of ischemic myocardial interstitial metabolites in the beating canine heart: measurement of adenosine using an improved microdialysis technique].
    Makita M
    Hokkaido Igaku Zasshi; 1991 May; 66(3):385-92. PubMed ID: 1885163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the parabolic relationship between biological activity and hydrophobicity of drugs: transport or protein binding?
    Franke R
    Experientia Suppl; 1976; 23():25-30. PubMed ID: 954940
    [No Abstract]   [Full Text] [Related]  

  • 32. A fraction of the ventricular myocardium that has the specificity of the cardiac beta-adrenergic receptor.
    Lefkowitz RJ; Haber E
    Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1773-7. PubMed ID: 4399664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nature of the transport adenosine triphosphatase-digitalis complex. VIII. The relationship between in vivo-formed (3-H-ouabain-Na+, K+-adenosine triphosphatase) complex and ouabain-induced positive inotropism.
    Allen JC; Entman ML; Schwartz A
    J Pharmacol Exp Ther; 1975 Jan; 192(1):105-12. PubMed ID: 123584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes.
    Bullough DA; Magill MJ; Firestein GS; Mullane KM
    J Immunol; 1995 Sep; 155(5):2579-86. PubMed ID: 7650388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac glycoside receptor in potassium depletion.
    Erdmann E; Bolte HD; Schoner W
    Recent Adv Stud Cardiac Struct Metab; 1975; 5():351-8. PubMed ID: 127357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of nucleoside transport binding sites in the human myocardium.
    Abd-Elfattah AS; Hoehner J; Wechsler AS
    Mol Cell Biochem; 1998 Mar; 180(1-2):105-10. PubMed ID: 9546636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine slows ischaemic metabolism in canine myocardium in vitro: relationship to ischaemic preconditioning.
    Vander Heide RS; Reimer KA; Jennings RB
    Cardiovasc Res; 1993 Apr; 27(4):669-73. PubMed ID: 8324803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Theoretical analysis of adenosine release from cardiac tissue as influenced by transport inhibitors.
    Wiener H; Schützenberger WG; Tuisl E; Kolassa N
    Can J Physiol Pharmacol; 1983 Aug; 61(8):946-9. PubMed ID: 6627134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General influence of physicochemical properties on drug-receptor combination.
    Flynn GL; Yalkowsky SH; Weiner ND
    J Pharm Sci; 1974 Feb; 63(2):300-4. PubMed ID: 4813262
    [No Abstract]   [Full Text] [Related]  

  • 40. Steric requirements for binding of adenosine to a membrane carrier in canine heart.
    Olsson RA; Gentry MK; Snow JA
    Biochim Biophys Acta; 1973 Jun; 311(2):242-50. PubMed ID: 4717764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.